{"id":372927,"title":"ARCHIVED Drug Establishment Licence (DEL) 2012 annual review: Notice to Stakeholders - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T18:08:58.101000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/2012-drug-establishment-licence-annual-review-evidence-demonstrate-drug.html","snippet":"ARCHIVED Notice to Stakeholders - New for 2012 Drug Establishment Licence (DEL) Annual Review - Evidence to Demonstrate Drug Good Manufacturing Practices (GMP) Compliance of Foreign Sites (PDF Version - 98 K) Contact Information October 31, 2011: Foreign Site GMP Evidence Receipt…","rawSnapshotUrl":"/api/snapshots/raw/372927","browseUrl":"https://replay.healtharchive.ca/job-6/20260411180858/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/2012-drug-establishment-licence-annual-review-evidence-demonstrate-drug.html#ha_snapshot=372927","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}